Papillomavirus Vaccines

The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Knowledge, Health Beliefs, and Vaccination Behavior Intentions

Impact of an e-Bug Educational Intervention on HPV Vaccine Uptake in Middle School Students

Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination

ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention

Let's K-Talk - HPV Study for Ethnic Koreans

Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV

Intervention for Human Papillomavirus Vaccine Acceptance in Mexican Mothers

Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors

A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults

HPV Vaccine Integrated Service Implementation Research in Cameroon

HPV Vaccine Integrated Service Implementation Research in Ethiopia

Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination

Effectiveness of HPV Vaccine in Thai Adult Women

Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination

Changes in the Prevalence of Oncogenic HPV Types

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.

Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older